This study has the general objective of observing walking parameters during a clinical test to objectively estimate fatigue in patients with neuromuscular diseases. Furthermore, the investigators want to evaluate the feasibility of collecting physical activity in daily life conditions during a one-week monitoring period using a wearable sensor.
Study Type
OBSERVATIONAL
Enrollment
120
inapplicable
Scientific Institute IRCCS E. Medea - Sede di Bosisio Parini
Bosisio Parini, Lecco, Italy
RECRUITINGScientific Institute IRCCS E. Medea - Polo di Conegliano
Conegliano, Treviso, Italy
NOT_YET_RECRUITINGVariation in walking speed during a 6-minutes walking test
Variation in walking speed calculated as difference between the first and the final minute of the a 6-minutes walking test
Time frame: Baseline
Subjective fatigue
Evaluation of subjective fatigue using the Fatigue Severity Scale (FSS). The minimum value is 0, the maximum is 63. Higher scores mean worse outcome.
Time frame: Baseline
Clinical progression of the neuromuscular disease
Progression of the neuromuscular disease using the Motor Function Measure-32 (MFM-32); the minimum score is 0, the maximum score is 100. Higher values mean better outcome.
Time frame: Baseline
Clinical progression of the neuromuscular disease
Progression of the neuromuscular disease using the Hammersmith Functional Motor Scale- Expanded (HFMS-E); the minimum value is 0, the maximum value is 69. Higher values mean better outcome.
Time frame: Baseline
Variation in gait variability during the 6-Minutes Walking Test
Variation of step duration during the 6MWT extracted from a wearable inertial sensor. Measured in coefficient of variation (%). Higher values mean worse outcome.
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.